Back to search

Article

Rhabdomyosarcoma fusion oncoprotein initially pioneers a neural signature in vivo

2024-07-16

Abstract excerpt

Fusion-positive rhabdomyosarcoma is an aggressive pediatric cancer molecularly characterized by arrested myogenesis. The defining genetic driver, PAX3::FOXO1, functions as a chimeric gain-of-function transcription factor. An incomplete understanding of PAX3::FOXO1’s in vivo epigenetic mechanisms has hindered therapeutic development. Here, we establish a PAX3::FOXO1 zebrafish injection model and semi-automated ChIP...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
526f7000-1d45-50ef-aaab-b29f5991417a
DOI
10.1101/2024.07.12.603270
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Rhabdomyosarcoma fusion oncoprotein initially pioneers a neural signature in vivoDOI 10.1101/2024.07.12.603270
Select a neighboring publication to make it the new centre.